The University Medical Center Utrecht is the main hospital of the city of Utrecht, Netherlands. It is affiliated with the Utrecht University. Since the foundation of the university in 1636 an academic hospital has existed in various forms.

During the past decade, UMC Utrecht Cancer Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UMC Utrecht Cancer Center" #1 sponsor was "Cellestia Biotech AG" with 1 trials, followed by "Crescendo Biologics Ltd." with 1 trials sponsored, "Genmab" with 1 trials sponsored, "Novartis Pharmaceuticals" with 1 trials sponsored and "Polyneuron Pharmaceuticals AG" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "UMC Utrecht Cancer Center" are "Adenoid Cystic Carcinoma" (1 trials), "Advanced and/or Metastatic Solid Tumours" (1 trials), "Anti-MAG Neuropathy" (1 trials), "Breast Cancer" (1 trials) and "Cervical Cancer" (1 trials). Many other conditions were trialed in "UMC Utrecht Cancer Center" in a lesser frequency.

Most popular intervention types in "UMC Utrecht Cancer Center" are "Drug" (4 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "4-L-[131I]iodo-phenylalanine (131I-IPA)" (1 trials), "CB-103" (1 trials), "CB307" (1 trials), "Enapotamab vedotin (HuMax-AXL-ADC)" (1 trials) and "PPSGG" (1 trials). Other intervention names were less common.

The vast majority of trials in "UMC Utrecht Cancer Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "UMC Utrecht Cancer Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in UMC Utrecht Cancer Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UMC Utrecht Cancer Center, 5 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".